• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本 COVID-19 患者中的肥胖悖论。

The obesity paradox in Japanese COVID-19 patients.

机构信息

Infection Control Committee, Shimonoseki City Hospital, Shimonoseki, Japan.

Department of Anesthesiology, Shimonoseki City Hospital, Shimonoseki, Japan.

出版信息

Int J Med Sci. 2023 Sep 11;20(11):1508-1512. doi: 10.7150/ijms.86933. eCollection 2023.

DOI:10.7150/ijms.86933
PMID:37790846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10542187/
Abstract

To investigate the effect of obesity on mortality and invasive respiratory care (IRC) in patients with COVID-19. We studied 1,105 patients for 34 months and collected data. The primary outcome was all-cause death at 29 days. The secondary outcome was IRC indicated by a pulse oximetry rate below 93% at a mask oxygenation rate of 5 L/min or more. Age- and sex-adjusted multivariate regression analysis for 29-day deaths showed the significance of body mass index (BMI) > 19.6 kg/m (odds ratio 0.117, 95% confidence interval 0.052-0.265, <0.001). The graphs with BMI in the abscissa showed, within a BMI between 11 and 25 kg/m, a decreasing pattern for mortality and IRC rate, and no increase in overweight. In Japanese COVID-19 patients, the risk of mortality and the IRC rate decreased in underweight patients and remained low in overweight patients, suggesting the importance of the obesity paradox.

摘要

探讨肥胖对 COVID-19 患者死亡率和侵入性呼吸支持(IRC)的影响。我们对 1105 例患者进行了 34 个月的研究,并收集了数据。主要结局是 29 天的全因死亡。次要结局是指在面罩给氧率为 5 L/min 或更高时,脉搏血氧饱和度率低于 93%的 IRC。对 29 天死亡率进行年龄和性别调整的多变量回归分析显示,体重指数(BMI)>19.6 kg/m(比值比 0.117,95%置信区间 0.052-0.265,<0.001)具有统计学意义。BMI 为横坐标的图表显示,在 BMI 为 11 至 25 kg/m 之间,死亡率和 IRC 率呈下降趋势,而超重患者没有增加。在日本 COVID-19 患者中,体重不足患者的死亡率和 IRC 率降低,超重患者的死亡率和 IRC 率保持较低水平,这表明肥胖悖论的重要性。

相似文献

1
The obesity paradox in Japanese COVID-19 patients.日本 COVID-19 患者中的肥胖悖论。
Int J Med Sci. 2023 Sep 11;20(11):1508-1512. doi: 10.7150/ijms.86933. eCollection 2023.
2
Impact of body mass index on long-term outcomes in Japanese patients following percutaneous coronary intervention: The Juntendo PCI Registry.体重指数对日本经皮冠状动脉介入治疗患者长期结局的影响:Juntendo PCI 注册研究。
J Cardiol. 2018 Sep;72(3):208-214. doi: 10.1016/j.jjcc.2018.02.007. Epub 2018 Mar 14.
3
The obesity paradox in patients with acute coronary syndromes over 2 decades - the ACSIS registry 2000-2018.20 余年来急性冠状动脉综合征患者的肥胖悖论:ACSIS 登记研究 2000-2018。
Int J Cardiol. 2023 Jun 1;380:48-55. doi: 10.1016/j.ijcard.2023.03.038. Epub 2023 Mar 20.
4
Gestational diabetes mellitus and COVID-19: results from the COVID-19-Related Obstetric and Neonatal Outcome Study (CRONOS).妊娠期糖尿病与 COVID-19:COVID-19 相关产科和新生儿结局研究(CRONOS)的结果。
Am J Obstet Gynecol. 2022 Oct;227(4):631.e1-631.e19. doi: 10.1016/j.ajog.2022.05.027. Epub 2022 May 14.
5
Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry.新冠肺炎中是否存在肥胖悖论?国际 HOPE-COVID-19 注册研究的观点。
Obes Res Clin Pract. 2021 May-Jun;15(3):275-280. doi: 10.1016/j.orcp.2021.02.008. Epub 2021 Mar 3.
6
Obesity and mortality in critically ill COVID-19 patients with respiratory failure.肥胖与新冠肺炎呼吸衰竭危重症患者的死亡率。
Int J Obes (Lond). 2021 Sep;45(9):2028-2037. doi: 10.1038/s41366-021-00872-9. Epub 2021 Jun 10.
7
Association of the Obesity Paradox With Objective Physical Activity in Patients at High Risk of Sudden Cardiac Death.肥胖悖论与高危心源性猝死患者客观体力活动的相关性。
J Clin Endocrinol Metab. 2020 Dec 1;105(12). doi: 10.1210/clinem/dgaa659.
8
Excess body weight is an independent risk factor for severe forms of COVID-19.超重是 COVID-19 严重症状的一个独立危险因素。
Metabolism. 2021 Apr;117:154703. doi: 10.1016/j.metabol.2021.154703. Epub 2021 Jan 6.
9
The influence of polyvascular disease on the obesity paradox in vascular surgery patients.多血管疾病对血管外科学患者肥胖悖论的影响。
J Vasc Surg. 2011 Feb;53(2):399-406. doi: 10.1016/j.jvs.2010.08.048. Epub 2010 Oct 20.
10
Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020.美国新冠肺炎住院患者中超重和肥胖相关的疾病负担:对2020年4月1日至2020年10月31日期间首要医疗保健数据库的分析
J Med Econ. 2023 Jan-Dec;26(1):376-385. doi: 10.1080/13696998.2023.2183679.

本文引用的文献

1
Rox Index Dynamics According to High Flow Nasal Cannula Success in Intensive Care Unit Patients with COVID-19-Related Acute Respiratory Failure.根据 COVID-19 相关急性呼吸衰竭的 ICU 患者高流量鼻导管治疗成功情况的罗克指数动态变化。
Balkan Med J. 2023 Mar 8;40(2):111-116. doi: 10.4274/balkanmedj.galenos.2022.2022-6-31. Epub 2023 Jan 30.
2
Body mass index and clinical outcome of severe COVID-19 patients with acute hypoxic respiratory failure: Unravelling the "obesity paradox" phenomenon.体重指数与急性低氧性呼吸衰竭的重症 COVID-19 患者的临床结局:揭开“肥胖悖论”现象。
Clin Nutr ESPEN. 2022 Oct;51:377-384. doi: 10.1016/j.clnesp.2022.07.016. Epub 2022 Aug 6.
3
Obesity Impact on SARS-CoV-2 Infection: Pros and Cons "Obesity Paradox"-A Systematic Review.
肥胖对严重急性呼吸综合征冠状病毒2感染的影响:利弊与“肥胖悖论”——一项系统综述
J Clin Med. 2022 Jul 2;11(13):3844. doi: 10.3390/jcm11133844.
4
Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression.肥胖与 COVID-19 严重程度和死亡率的关联:一项更新的系统评价、荟萃分析和荟萃回归研究。
Front Endocrinol (Lausanne). 2022 Jun 3;13:780872. doi: 10.3389/fendo.2022.780872. eCollection 2022.
5
Association of body mass index with COVID-19 related in-hospital death.体重指数与新型冠状病毒肺炎相关院内死亡的关联
Clin Nutr. 2022 Dec;41(12):3137. doi: 10.1016/j.clnu.2022.03.010. Epub 2022 Mar 25.
6
The neutrophil/lymphocyte ratio as a prognostic factor in COVID-19 patients: a case-control study.中性粒细胞/淋巴细胞比值作为 COVID-19 患者的预后因素:一项病例对照研究。
Eur Rev Med Pharmacol Sci. 2022 Feb;26(3):1056-1064. doi: 10.26355/eurrev_202202_28017.
7
The effect of age on ventilation management and clinical outcomes in critically ill COVID-19 patients--insights from the PRoVENT-COVID study.年龄对 COVID-19 危重症患者通气管理和临床结局的影响——来自 PRoVENT-COVID 研究的观察。
Aging (Albany NY). 2022 Jan 31;14(3):1087-1109. doi: 10.18632/aging.203863.
8
COVID-19 infection and body weight: A deleterious liaison in a J-curve relationship.COVID-19 感染与体重:呈 J 型曲线关系的有害关联。
Obes Res Clin Pract. 2021 Nov-Dec;15(6):523-535. doi: 10.1016/j.orcp.2021.10.006. Epub 2021 Nov 3.
9
Systemic corticosteroids for the treatment of COVID-19.全身性皮质类固醇治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Aug 16;8(8):CD014963. doi: 10.1002/14651858.CD014963.
10
Body mass index and Mini Nutritional Assessment-Short Form as predictors of in-geriatric hospital mortality in older adults with COVID-19.体重指数和简易营养评估量表简表作为新型冠状病毒肺炎老年患者老年医院死亡率的预测指标
Clin Nutr. 2022 Dec;41(12):2973-2979. doi: 10.1016/j.clnu.2021.07.025. Epub 2021 Jul 29.